glp-1 cv outcome trials Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes GLP-1 receptor agonists were developed
Description
doi: 10.1007/s40264-023-01392-3
Abrupt discontinuation of stimulants can cause withdrawal symptoms and ADHD symptom rebound, whilst stopping Wegovy typically results in weight regain
Psychological & Physiological Dependence Patients may develop a psychological or physiological reliance on GLP-1 medications, complicating the discontinuation process
The available data doesnt show major differences between the two drugs for menstrual effects
(2015) 81 with some modifications
